Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.40
Bid: 33.90
Ask: 34.40
Change: -2.60 (-7.03%)
Spread: 0.50 (1.475%)
Open: 36.10
High: 36.10
Low: 33.60
Prev. Close: 37.00
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Apr 2021 07:00

RNS Number : 4139U
Argentex Group PLC
06 April 2021
 

6 April 2021

Argentex Group PLC

Full Year Trading Update

 

Argentex Group PLC, ("Argentex" or "the Group"), the provider of foreign exchange services to institutions, corporates and high net worth private individuals, today issues a trading update for the 12 months to 31 March 2021.

 

Highlights*:

 

· Full year revenue stable at £28.1m (2020: £28.9m)

· Robust H2 revenue of £16.4m (2020: £15.2m)

· Record growth in customer acquisition with 665 new corporate clients added (2020: 479)

· Significant operational progress including a move to new offices

 

Argentex is expected to report revenues in line with expectations of £28.1 million for the 12 months to 31 March 2021 (2020: £28.9 million) with Foreign Exchange ("FX") Turnover exceeding £12.5bn (2020: £12bn). This was driven by a significant improvement in trading in H2 with expected revenue of £16.4m (2020: £15.2m) as a result of a return in client confidence and trading activity, which had been deferred from 2020.

 

The strong growth in the rate of new client acquisition has continued with 665 new corporate clients added in the twelve months. The Group continued to maintain its prudent and proactive approach to risk management, focusing on the quality and diversification of its book with bad debt levels remaining at historically low levels.

 

Despite spending the majority of the financial year working remotely, the Group successfully navigated all three national lockdowns and continued to invest in both front and back office talent along with a move to new, substantially larger Covid-secure offices giving the Group ample capacity to meet its growth targets.

 

Harry Adams, CEO, commented:

 

"Despite the unexpected and challenging market backdrop, we have continued to deliver our stated growth strategy, albeit at a slower pace in this financial year. We are seeing a resurgence in client trading to pre-pandemic levels following the deferral of client activity during the first half and we expect that trend to continue with the arrival of a more positive macro-economic environment.

 

"During the period we continued to invest in technology, our systems and our people and we have a strengthened management team and new premises to help accelerate our growth ambitions.

 

"The resilience of our people and business model has been a defining factor during the period and I am confident we are well positioned to deliver for a growing client base and maintain our expected growth trajectory."

 

*for Argentex LLP (the Group's FCA regulated trading subsidiary)

 

-ENDS-

 

For further information please contact:

Harry Adams - CEO

Jo Stent - CFO

(Via FTI Consulting)

FTI Consulting (Financial PR)

Ed Berry, Shiv Talwar, Ambrose Fullalove

Telephone: 07703 330 199

argentex@fticonsulting.com 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBNFBKDDQK
Date   Source Headline
3rd May 20247:00 amRNSRetail Offer
2nd May 20245:55 pmRNSResults of Placing
2nd May 20247:01 amRNSProposed Fundraise
2nd May 20247:00 amRNSFull Year Results For the Year Ended 31/12/2023
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.